BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bowry SK, Kircelli F, Himmele R, Nigwekar SU. Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation. Clin Kidney J 2021;14:i59-71. [PMID: 34987786 DOI: 10.1093/ckj/sfab185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei Q, Feng S, Zhang Z, Liu L, Wu L. A high-protein retained PES hemodialysis membrane with tannic acid as a multifunctional modifier. Colloids and Surfaces B: Biointerfaces 2022;220:112921. [DOI: 10.1016/j.colsurfb.2022.112921] [Reference Citation Analysis]
2 Chen CY, Liou HH, Chang MY, Wang HH, Lee YC, Ho LC, Lin TM, Hung SY. The use of a low-flux hemo-dialyzer is associated with impaired platelet aggregation in patients undergoing chronic hemodialysis. Medicine (Baltimore) 2022;101:e31623. [PMID: 36316899 DOI: 10.1097/MD.0000000000031623] [Reference Citation Analysis]
3 Kaps L, Schleicher EM, Medina Montano C, Bros M, Gairing SJ, Ahlbrand CJ, Michel M, Klimpke P, Kremer WM, Holtz S, Boedecker-lips SC, Galle PR, Kraus D, Schattenberg JM, Labenz C, Weinmann-menke J. Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF). JCM 2022;11:2782. [DOI: 10.3390/jcm11102782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bonomini M, Piscitani L, Di Liberato L, Sirolli V. Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy. Biomedicines 2022;10:844. [DOI: 10.3390/biomedicines10040844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]